Actively Recruiting

Early Phase 1
Age: 18Years +
All Genders
NCT05380349

Personalized Cancer Stem Cell High-Throughput Drug Screening for Glioblastoma

Led by Swedish Medical Center · Updated on 2025-05-16

10

Participants Needed

1

Research Sites

188 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Proposed treatment of subjects with newly diagnosed glioblastoma with novel personalized drug regimens identified to be effective in vitro using cancer stem cells derived from their individual tumors, alongside standard of care radiation and TMZ.

CONDITIONS

Official Title

Personalized Cancer Stem Cell High-Throughput Drug Screening for Glioblastoma

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Histological diagnosis of glioblastoma (GBM, WHO grade 4)
  • Age 18 years or older
  • Life expectancy greater than 6 months
  • Tumor accessible for surgery with intent for gross or near total resection
  • Karnofsky Performance Status (KPS) of 70 or higher
  • No prior systemic anti-cancer treatment
  • Negative for HIV, Hepatitis B, and Hepatitis C
  • Hemoglobin greater than 8 g/dL
  • Absolute neutrophil count greater than 1,000/mm3
  • Platelet count greater than 100,000/mm3
  • Creatinine less than 2 mg/dL
  • Liver enzymes (ALP, AST, ALT) less than 3 times the upper limit of normal
Not Eligible

You will not qualify if you...

  • Presence of metastatic disease
  • Conditions that obscure toxicity assessment or dangerously affect drug metabolism
  • Serious ongoing medical illnesses
  • Poorly controlled high blood pressure
  • History of heart attack or unstable angina within the past 6 months
  • History of stroke or transient ischemic attack within the past 6 months

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Swedish Medical Center

Seattle, Washington, United States, 98122

Actively Recruiting

Loading map...

Research Team

C

Charles S Cobbs, M.D.

CONTACT

P

Parvinder Hothi, Ph.D.

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SEQUENTIAL

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here